CA
MLAB icon

Clearstead Advisors’s Mesa Laboratories MLAB Stock Holding History

Clearstead Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Buy
+13
New +$1.31K ﹤0.01% 2624
2026
Q1 		– Sell
-1
Closed -$79 – 2622
2025
Q4 		$79 Sell
1
-34
-97% -$2.59K ﹤0.01% 2554
2025
Q3 		$2.35K Sell
35
-59
-63% -$4.25K ﹤0.01% 2405
2025
Q2 		$8.86K Sell
94
-34
-27% -$3.73K ﹤0.01% 1923
2025
Q1 		$15.2K Sell
128
-22
-15% -$3K ﹤0.01% 1491
2024
Q4 		$19.8K Hold
150
– – ﹤0.01% 1393
2024
Q3 		$19.5K Hold
150
– – ﹤0.01% 1425
2024
Q2 		$13K Buy
150
+135
+900% +$14.1K ﹤0.01% 1486
2024
Q1 		$1.75K Hold
15
– – ﹤0.01% 1332
2023
Q4 		$1.57K Sell
15
-1
-6% -$97 ﹤0.01% 1326
2023
Q3 		$1.68K Buy
+16
New +$2.05K ﹤0.01% 1424
2022
Q2 		– Sell
-10
Closed -$3K – 1378
2022
Q1 		$3K Buy
+10
New +$2.72K ﹤0.01% 1150

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Clearstead Advisors's MLAB Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 13 shares worth $1.29K. The stake represents ﹤0.01% of the portfolio and ranks #2624 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in MLAB as recently as Q4 2025.

Clearstead Advisors first reported a position in MLAB in Q1 2022 and has held it in 12 quarters since. The position peaked at $19.8K in Q4 2024. 49 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Clearstead Advisors held 13 shares of Mesa Laboratories worth $1.29K as of Q2 2026.
  • Mesa Laboratories was a new Clearstead Advisors position in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2624 holding.
  • Clearstead Advisors first reported a position in Mesa Laboratories in Q1 2022 and has held it in 12 quarters since.
  • Clearstead Advisors's Mesa Laboratories position peaked at $19.8K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.